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Objectives: perioperative stroke reduces the clinical effectiveness of carotid endarterectomy (CEA). Postoperative
thrombotic stroke may be reduced in incidence by the use of transcranial Doppler-directed Dextran-40 therapy. This
programme requires the purchase of additional equipment and employment of more staff. This study examined whether
this additional financial outlay was cost-effective in terms of saving expenditure by preventing postoperative thrombotic
stroke.
Materials and methods: data was collected prospectively on a series of 600 consecutive CEAs. The costs of the monitoring
programme were analysed over 1- and 5-year periods. Formulae were derived allowing other units to calculate whether
this technique will be cost-effective for them.
Results: after the introduction of TCD monitoring the postoperative thrombotic stroke rate fell from 2.7% to 0% (8
strokes prevented). Our local unit cost for the treatment of stroke was £25 702. After allowing for the additional costs of
the monitoring programme, we calculate that postoperative TCD has saved £171 393.
Conclusions: postoperative TCD monitoring is a clinically effective and also cost-effective method of reducing the stroke
rate associated with CEA. For units performing more than 50 CEAs per year who experience occasional postoperative
carotid thrombosis, its introduction should be considered.
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Introduction (MCA) after CEA are at risk of postoperative cerebral
ischaemia, with 38% developing a stroke and 25% a
Carotid endarterectomy (CEA) has a proven role in the TIA.4,5 It has been shown that these postoperative
thromboses can be prevented by TCD-directed Dex-reduction of thromboembolic stroke in symptomatic
patients with significant carotid stenoses.1,2 Its overall tran-40 therapy when appropriate.4,5
Although there is now a proven benefit in termseffectiveness, however, is inextricably linked to the
initial operative risk. of reducing postoperative thrombotic stroke numbers
using this technology,3–5 there is no evidence of itsPrevious work has shown that a policy of intra-
operative TCD and completion angioscopy resulted in actual cost-effectiveness. A study was therefore under-
taken to examine whether the extra financial costsa significant decline in intraoperative stroke.3,4 How-
ever, this had no effect on the number of postoperative involved in setting up and maintaining this post-
operative monitoring programme were outweighedstrokes that continued to occur as a result of carotid
artery thrombosis after endarterectomy. In October by the cost-savings in terms of reduced numbers of
strokes.1995, a revised postoperative monitoring programme
was implemented, whereby all patients underwent 6 h
of TCD monitoring following surgery. Previous work
has shown that 50–60% of patients who have significant Patients and Methods
rates of embolisation to the middle cerebral artery
The outcome of all patients following CEA has been
recorded prospectively in our unit since 1992, when
* Please address all correspondence to: P. D. Hayes, Department the current quality control research programme wasof Surgery, Clinical Sciences Building, Leicester Royal Infirmary,
Leicester, U.K. implemented. In October 1995 a revised protocol was
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Table 1. Comparison of patient attributes and risk factors for each Table 2. Start-up and annual capital costs of running a post-
operative stroke prevention programme using TCD.of the two groups.
Pre-Oct 95 Post-Oct 95 First-year start-up costs
Purchase of TCD machine £11 500
Vascular technician* £9 460% male 68 70
Average age 67.4 69.8 Annual service Free
Presentation (%) Total £20 960
AF or TIA 53.5 54.6
stroke 31.2 28.9 Annual costs thereafter†
asymptomatic 15.3 16.5 Vascular technician £9 460
TCD servicing £1 150
Total £10 610
introduced to reduce the number of perioperative * Includes National Insurance charges and pension payments.
strokes seen following CEA. Data from the 300 CEAs † Before adjustment for annual inflation.
performed on either side of this date have been com-
pared, in terms of outcomes and costs. The number
of patients was selected at an arbitrary level before
Table 3. Perioperative complications of CEA.data analysis commenced in order to prevent selection
bias after the data had been examined. The figure of 1992–95 (%) 1995–97 (%) p-value
300 patients was selected as the rate of postoperative
Operations 300 300 –carotid thrombosis was known to be relatively low.
The two groups were well-matched in terms of age, All intraoperative events:
Intraoperative ICAsex, presenting symptoms (see Table 1). There were
thrombosis 1 (0.3%) 1 (0.3%) NSno statistically significant differences between the two All postoperative events:
groups. Postoperative ICA 8 (2.7%) 0 <0.01
thrombosis
Vein patch rupture 3 (1.0%) 0 <0.05
Intracranial haemorrhage 1 (0.3%) 3 (1.0%) NS
Multi-organ failure 1 (0.3%) 0 NSOperative procedure Fatal MI 0 1 (0.3%) NS
Hyperperfusion syndrome 1 (0.3%) 0 NS
Post-MI embolic stroke 0 1 (0.3%) NSCarotid endarterectomy was performed in a stand-
Unknown cause of stroke* 4 (1.3%) 0 <0.01ardised manner throughout the two study periods. Death and any stroke 19 (6.3%) 6 (2.0%) <0.01
The operation was undertaken with the patient under
* Investigation including carotid duplex, head CT scan and echo-normocarbic, normotensive general anaesthesia using
cardiogram.systemic heparinisation. A Pruitt-Inahara shunt was
used in all cases. The proximal and distal intimal
steps were tacked down using 7-0 prolene and all Any event occurring within 30 days of the CEA wasarteriotomies closed with a patch angioplasty. Intra- considered to be postoperative. Any new neurologicaloperative TCD was performed using a 2 MHz fixed, deficit lasting longer than 24 h was classified as ahead probe. Completion angioscopy was performed stroke. All of these patients were assessed by head CTin all cases. scan, carotid duplex and further TCD, with or withoutSince October 1995, all patients with an accessible a return to theatre for further exploration. The severitycranial window were monitored for 6 h post- of the stroke was determined by a neurologist ac-operatively using the TCD. Patients who either ex- cording to the Oxford Handicap Scoring system.6hibited significant numbers of particulate emboli (>25
in a 10-min period), or distorted the waveform, in the
middle cerebral artery, are at risk of complete occlusion
of the carotid artery.4 These patients were then treated Procedure costs
with 10% Dextran-40, beginning at a rate of 20 ml/h.
If the number of emboli failed to decline then the rate Costs relating to the procedure can be broken down
into capital expenditure on single items, consumablesof the Dextran-40 infusion was increased by 5 ml/h
every 10 min, to a maximum rate of 40 ml/h. Once the and wages (see Table 2). The only consumable cost
was a bottle of Dextran-40 at £5.75, but only onerate of embolisation had stabilised, the Dextran-40
therapy was continued for 12 h. If the maximum dose bottle is needed every 20 CEAs (the rate of significant
embolisation is only 5%), making the per-patient costof Dextran-40 failed to control the embolisation, then
the patient was re-explored. £0.28.
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Table 4. The cost of monitoring per CEA as a function of time The cost of a stroke
and number of CEAs performed per year.
25 CEAs/year 50 CEAs/year 150 CEAs/ The cost of rehabilitating a patient after a stroke was
year derived from two sources, with the help of a health
economist (JW). The fact that, of all strokes that occur,Average costs/
CEA over first one-half are mild/moderate and one-half severe or
year £838.68 £419.48 £140.01 ultimately fatal was taken into account when cal-
Average costs/ culating the costs of stroke. The first of these, short-
CEA over 5 term care, was our local stroke-unit costings of in-years £507.48 £253.88 £84.81
patient medical therapy and then further out-patient
therapy by the Stroke Team. The average number of
extra in-patient bed days were 30, and this consisted
Table 5. This table indicates the total cost-savings, in terms of of 6 days in the acute stroke unit, 14 days in thestrokes prevented, that are made over the lifetime of a 5-year
rehabilitation ward and 10 days in a community hos-postoperative TCD programme, at given activity and complication
levels. The bold figures are cost-savings, and the standard type a pital setting. The cost of the first 20 days’ in-patient
cost-loss. stay was calculated by dividing the annual running
costs of the stroke and rehabilitation units by theNumber of thrombotic strokes per 100
CEAs performed number of patients admitted annually for stroke care.
The prices included an allowance for physiotherapy,No. of CEAs/year 1 2 3
occupational therapy and routine blood tests. The cost
10 £50 799 £37 048 £23 297 of stay averaged £4333. The further 10 days’ stay in
15 £43 924 £23 297 £2 671 the community hospital setting cost £1230. In addition,20 £37 048 £9 546 £17 956
a carotid duplex (£115), a CT head scan (£134.50), a30 £23 297 £17 956 £59 209
40 £9 546 £45 458 £100 462 chest X-ray (£9) and an ECG (£10), were costed for as
50 £4 205 £72 960 £141 715 part of the standard work-up for a stroke patient. The75 £38 583 £141 715 £244 848
further out-patient treatment costs were based on two100 £72 960 £210 470 £347 980
150 £141 715 £347 980 £554 245 prospective studies7,8 and came to £540.
The longer-term costs of stroke were based on two
Fig. 1. Overall potential savings of the use of TCD for varying complication rates.
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well-conducted, European, prospective trials.8,9 The The calculations of significance in Table 3 were based
on data that were not normally distributed and werecosts included were for the use of nursing homes, day
care and home helps. The prices were converted to therefore analysed using Fisher’s exact test or v2 as
appropriate. A value of p<0.05 was taken as significant.U.K. currency and then readjusted to 1997 prices using
the Hospital and Community Health Services Pay and
Price Index. The average additional cost of stroke care
in the years following the stroke was £2648 per year.
ResultsFollowing stroke, there is a mortality of 9.1% per
annum (Oxford Community Stroke Project),10 and this
Table 3 contains the outcomes of the 300 operations,gave an average life expectancy of 7.3 years. Therefore,
before and after the introduction of the revised moni-the average lifetime cost of post-stroke care was
toring programme. Of the 300 patients who were£19 330.
monitored using TCD, 15 patients developed sig-Totalling the above figures gave us a total cost for
nificant rates of embolisation and were treated withthe rehabilitation and care of the stroke patient of
Dextran-40 therapy. There were no complications aris-£25 701.50. This did not include a calculation for po-
ing directly from the use of low dose Dextran-40tential loss of earnings through disability due to stroke.
therapy in these 15 patients. Previous work suggestsThis figure is in line with other studies9,11 that have
that, without Dextran-40 therapy, seven or eight (50–examined the short- and long-term cost of stroke. The
60%) of these patients would suffer postoperativecosts quoted in these studies are £23 328 and £29 531,
thrombotic strokes.3–5 The data in Table 3 concur withgiving an average of £26 430.
these studies. This shows that there has been a sig-As we were interested primarily in the extra costs
nificant decrease in the number of postoperativegenerated by our postoperative monitoring pro-
thrombotic strokes seen since the introduction of thegramme to reduce postoperative stroke during CEA,
revised monitoring programme from eight to zerothe cost of performing the primary procedure or rou-
(Fisher’s exact test, p<0.01). Although the death andtine in-hospital recovery was not calculated. These
any stroke rate was higher in the first group, if theshould have remained constant (allowing for inflation)
postoperative thrombotic strokes are excluded, thenbetween the pre- and post-October 1995 groups.
there is no significant difference (v2=3.56, p=0.2).
There were also four strokes in the first 300 patients,
for which no cause could be identified despite in-Formula
vestigation with carotid duplex, head CT scan and
echocardiogram. These strokes are likely to be sec-Two formulae were used to derive costs and benefits.
ondary to prolonged postoperative embolisation thatThe first is for calculation of the additional cost of
did not proceed to carotid occlusion secondary toimplementing the postoperative monitoring pro-
thrombosis.gramme per CEA performed.
There were three intracranial haemorrhages in the
second group, compared to one in the first. None offixed costs per year
number of CEAs per year
+consumable costs per patient (1)
the three patients in the second group had been treated
with Dextran-40. Treatment with Dextran-40 does not
The second determines what it cost to prevent a appear to increase the risk of intracranial haemorrhage
single postoperative thrombotic stroke. If this figure in our study group.
is negative, it indicates that a net saving will be made
with each stroke prevented. This formula does not
calculate the potential savings of the programme. The
term, “thrombotic strokes/100 CEAs”, is the number Local cost savings
of postoperative carotid thromboses that are seen for
every 100 CEAs performed; it is not dependent upon The additional cost of postoperative monitoring 300
time. patients over the 27-month period was £34 223. This
The second formula calculates the total potential equates to an additional cost per case of £114 (i.e.
savings of the postoperative monitoring programme. £34 223‚300 cases).
However, the stroke rate due to postoperative
Savings=
thrombosis fell from 2.7% to 0% as a result of TCD-(Cost of stroke)(CEAs/year)(thrombotic strokes/100 CEAs)
100
(2) directed Dextran-40 therapy, thus preventing eight
strokes over the course of the programme. The cost of-(Cost of TCD/year)
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the additional monitoring for each stroke prevented not without its limitations. Currently, 93% of patients
who undergo CEA have an accessible temporal win-was £4278 (i.e. £34 223‚eight strokes).
However, since the cost of stroke rehabilitation and dow and can be monitored in the postoperative period
by the TCD. However, this rate is only achieved bycare was £25 702 per patient, calculations indicate that
£171 393 has been saved (i.e. (£25 702·eight strokes having experienced technicians and a careful 30-min
preoperative evaluation to identify the best site atprevented)-£34 223)) and also preserved the quality
of life for eight patients. which to monitor the middle cerebral artery. The actual
percentage of patients successfully monitored in the
postoperative period was 90%. The additional 3% were
not monitored due to technical failure (equipment or
Discussion staff). There were no postoperative thrombotic strokes
in patients with no temporal window.
Carotid endarterectomy is under renewed scrutiny. In It takes about 6 months to fully train a technician
order to establish it as a clinically effective method of to set up the TCD, and monitor during the operation
stroke prevention, perioperative stroke rates must be and in the postoperative period for emboli. If there is
reduced to a minimum. Previous work has shown that only one technician in a unit, then periods when
the intraoperative stroke rate can be reduced from 4% the technician is absent may be problematic. In our
to 0.3% by the introduction of completion angioscopy experience, it is possible to train most surgeons to use
and intraoperative TCD.3 This quality-control pro- the equipment, to cover this area. There is currently
gramme had no effect on the rate of postoperative interest in the development of TCD machines that
thrombotic stroke, which remained static at 2.7%. have inbuilt emboli detection systems, thus negating
It has been noted that for 2–3 h, before patients the need for the TCD technician to remain with the
thrombose their carotid arteries completely, significant patient for 3 h postoperatively. These systems are cur-
rates of embolisation (more than 25 in a 10-min period) rently being evaluated.
can be detected by TCD. The administration of Dex-
tran-40 can reduce the risk of carotid thrombosis in
patients who have significant numbers of emboli.4,5
A policy of routine Dextran-40 administration to all Extrapolating cost-savings to other centres
postoperative CEAs prevented carotid thrombosis.
However, it was associated with a significant increase The figures that have been presented above apply to
our local unit. Although some of the costs can bein the numbers of neck haematomas seen, occasional
episodes of cardiac failure and one death through generalised (e.g. stroke care), other variables will differ
significantly between units. The information providedmulti-organ failure. This prompted us to use the TCD
to identify those patients at high risk of postoperative below is to enable interested units to use their own
figures to decide whether postoperative TCD is cost-carotid thrombosis, i.e. those with large numbers of
emboli in the postoperative period, and use the Dex- effective for them, should they wish to use it. The
figures used for illustration are those derived fromtran-40 therapy selectively in these patients only. Using
this protocol, there have been no postoperative throm- this paper. Once the carotid programme exceeds 150
CEAs per year then the extra cost of a second TCDbotic strokes in our last 400 patients.12
There were also four strokes in the first 300 patients, machine needs to be addressed. These figures are not
presented here but could be derived from the figuresfor which no cause could be identified despite in-
vestigation with carotid duplex, head CT scan and and formulae provided.
The additional costs of running the programmeechocardiogram. It could be postulated that these are
strokes which were secondary to prolonged post- depend on two factors. The first is the number of
CEAs performed each year and the time-scale overoperative embolisation, that did not proceed to carotid
occlusion secondary to thrombosis. This may explain which the capital cost of the TCD machine is spread.
The additional costs per CEA were calculated fromwhy there were no unexplained strokes in the group
in whom postoperative TCD monitoring was used, as formula 1. This is illustrated in Table 4. The cost per
CEA performed falls as the cost of the programme isprolonged embolisation would have been detected
and treated in the second group. This potential further spread over time, and as the number of CEAs per year
rises.benefit of the revised monitoring programme is not
included in the analysis, as it cannot be proven. The most equitable way to approach the issue of
cost-effectiveness is to calculate where the break-evenThe use of a programme of TCD-directed Dextran-
40 therapy appears to be clinically effective, but it is point is, i.e. where the costs of the postoperative
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monitoring programme are equalled by the savings in The costs presented here represent the costs of
terms of the cost of the strokes prevented. Taking a healthcare in the U.K., which is relatively cheap com-
long-term view, we performed our costing over a 5- pared to North America and some areas of Europe;
year period. The total fixed costs of a 5-year pro- the potential cost-savings may be greater in these
gramme is £64 550. This figure is entirely independent areas. Finally, it has to be noted that this paper has
of the number of cases performed through the 5 years. counted only the financial cost of stroke, and not begun
The cost of a single stroke is £25 702. Thus, the number to account for the decreased quality of life in patients
of postoperative thrombotic strokes that need to be who have a stroke.
prevented over a 5-year period to break even is 2.35 (i.e.
£64 550‚£25 702). This means that if a unit experiences
more than two thrombotic strokes in a 5-year period
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postoperative TCD monitoring may be cost-effective.
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